These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 9278462

  • 21. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
    van Den Belt AG, Prins MH, Lensing AW, Castro AA, Clark OA, Atallah AN, Burihan E.
    Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. A randomized trial comparing 2 low-molecular-weight heparins for the outpatient treatment of deep vein thrombosis and pulmonary embolism.
    Wells PS, Anderson DR, Rodger MA, Forgie MA, Florack P, Touchie D, Morrow B, Gray L, O'Rourke K, Wells G, Kovacs J, Kovacs MJ.
    Arch Intern Med; 2005 Apr 11; 165(7):733-8. PubMed ID: 15824291
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection.
    Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J.
    Arch Intern Med; 1998 Sep 14; 158(16):1809-12. PubMed ID: 9738611
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S, Quinlan DJ, Agnelli G, Eikelboom JW.
    Circulation; 2004 Aug 10; 110(6):744-9. PubMed ID: 15262836
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study.
    Meyer G, Brenot F, Pacouret G, Simonneau G, Gillet Juvin K, Charbonnier B, Sors H.
    Thromb Haemost; 1995 Dec 10; 74(6):1432-5. PubMed ID: 8772215
    [Abstract] [Full Text] [Related]

  • 35. Inverse relationship of bleeding risk with clot burden during pulmonary embolism treatment with LMW heparin.
    Wang C, Zhai Z, Yang Y, Cheng Z, Ying K, Liang L, Dai H, Huang K, Lu W, Zhang Z, Cheng X, Shen YH, Davidson BL, China National Venous Thromboembolism (VTE) Study Group.
    Clin Respir J; 2016 Sep 10; 10(5):596-605. PubMed ID: 25619125
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Tinzaparin in the treatment of venous thromboembolism.
    Pineo GF, Hull RD.
    Expert Opin Pharmacother; 2003 Dec 10; 4(12):2355-62. PubMed ID: 14640933
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of tinzaparin and acenocoumarol for the secondary prevention of venous thromboembolism: a multicentre, randomized study.
    Pérez-de-Llano LA, Leiro-Fernández V, Golpe R, Núñez-Delgado JM, Palacios-Bartolomé A, Méndez-Marote L, Colomé-Nafria E.
    Blood Coagul Fibrinolysis; 2010 Dec 10; 21(8):744-9. PubMed ID: 20885298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.